These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl. Goetz M; Surman CB; Mlynarova E; Krsek P J Clin Psychopharmacol; 2012 Apr; 32(2):300-2. PubMed ID: 22388167 [No Abstract] [Full Text] [Related]
47. An update on attention deficit disorder. Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391 [No Abstract] [Full Text] [Related]
48. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder. Lurie S; O'Quinn A J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171 [TBL] [Abstract][Full Text] [Related]
51. [Joint position of the Guideline Group of the European Network for Hyperkintetic Disorders (EUNETHYDIS) and the German Central ADHD Network for ECG Recording on methylphenidate prescriptions]. Banaschewski T; Z Kinder Jugendpsychiatr Psychother; 2008 Nov; 36(6):437-9. PubMed ID: 19034859 [No Abstract] [Full Text] [Related]
52. Acute focal dystonic reaction after acute methylphenidate treatment in an adolescent patient. Tekin U; Soyata AZ; Oflaz S J Clin Psychopharmacol; 2015 Apr; 35(2):209-11. PubMed ID: 25607477 [No Abstract] [Full Text] [Related]
53. Quillivant XR--an extended release oral suspension of methylphenidate. Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227 [No Abstract] [Full Text] [Related]